SYSTEM AND METHOD FOR COMMUNICATING IN A TIME DIVISION MULTIPLE ACCESS (TDMA) MESH NETWORK HAVING MINIMIZED END-TO-END LATENCY
    41.
    发明申请
    SYSTEM AND METHOD FOR COMMUNICATING IN A TIME DIVISION MULTIPLE ACCESS (TDMA) MESH NETWORK HAVING MINIMIZED END-TO-END LATENCY 有权
    用于在时分多址(TDMA)网络中进行通信的系统和方法具有最小化的端到端延迟

    公开(公告)号:US20080165745A1

    公开(公告)日:2008-07-10

    申请号:US11620756

    申请日:2007-01-08

    IPC分类号: H04J3/00

    CPC分类号: H04W28/18 H04W28/24 H04W84/18

    摘要: A system and method for communicating includes a plurality of wireless nodes forming a Time Division Multiple Access (TDMA) mesh network. Each wireless node includes a transmitter and receiver and is operative for transmitting data packets across the TDMA mesh network from a source node through intermediate nodes to a destination node using a TDMA epoch such that a slot of channel time is allocated in both time and TDMA epoch prior to a wireless node transmitting the data packet.

    摘要翻译: 用于通信的系统和方法包括形成时分多址(TDMA)网状网络的多个无线节点。 每个无线节点包括发射机和接收机,并且可操作用于使用TDMA时代从TDMA节点从源节点通过中间节点向目的地节点发送数据分组,使得在时间和TDMA时代分配信道时间的时隙 在无线节点发送数据分组之前。

    Hypoglycemic thiazolidinediones and intermediates
    46.
    发明授权
    Hypoglycemic thiazolidinediones and intermediates 失效
    低血糖噻唑烷二酮类和中间体

    公开(公告)号:US06329408B1

    公开(公告)日:2001-12-11

    申请号:US08458071

    申请日:1995-06-01

    申请人: David A. Clark

    发明人: David A. Clark

    IPC分类号: A61K31421

    摘要: Optically pure thiazolidinedione alcohols and ethers, and synthetic intermediates for preparing said alcohols and ethers. These compounds have utility as hypoglycemic and hypocholesterolemic agents.

    摘要翻译: 光学纯的噻唑烷二酮醇和醚,以及用于制备所述醇和醚的合成中间体。 这些化合物可用作低血糖和低胆固醇血症。

    Integrated order selection and distribution system
    47.
    发明授权
    Integrated order selection and distribution system 有权
    综合订单选择和分配系统

    公开(公告)号:US06208908B1

    公开(公告)日:2001-03-27

    申请号:US09300069

    申请日:1999-04-27

    IPC分类号: G06F700

    CPC分类号: G06Q10/087

    摘要: An integrated order selection and distribution system is provided for selecting and delivering a plurality of articles associated with a preselected customer order. The system includes discrete article receptacles, a conveyor, and a plurality of pack stations. The receptacles releasably retain articles associated with a preselected customer order. Each receptacle is transported to predetermined locations within the system by the conveyor. The pack stations are arranged along the direction of movement of the conveyor to receive the articles to be discharged from the receptacles. A system controller tracks the location of the receptacles in the system and generates a signal that causes each receptacle to discharge its articles at a predetermined location, relative to the pack stations. In the preferred embodiment, the system controller assigns each receptacle to at least one of the pack stations in round-robin fashion based upon the type of articles to be discharged.

    摘要翻译: 提供集成的订单选择和分配系统用于选择和递送与预选客户订单相关联的多个商品。 该系统包括分立的物品接收器,输送机和多个包装站。 容器可释放地保留与预选客户订单相关联的物品。 每个容器通过输送机输送到系统内的预定位置。 包装站沿输送机的运动方向布置,以接收从容器排出的物品。 系统控制器跟踪系统中的容器的位置,并产生一个信号,使每个容器相对于包装站在预定位置排放其物品。 在优选实施例中,系统控制器基于要排出的物品的类型,以循环方式将每个容器分配给至少一个包装站。

    Thiazolidinedione hypoglycemic agents
    50.
    发明授权
    Thiazolidinedione hypoglycemic agents 失效
    噻唑烷二酮降血糖药

    公开(公告)号:US5120754A

    公开(公告)日:1992-06-09

    申请号:US679898

    申请日:1991-04-03

    摘要: Hypoglycemic thiazolidine-2,4-dione derivatives of the formula ##STR1## wherein the dotted line represents a bond or no bond; A and dB are each independently CH or N, with the proviso that when A or B is N, the other is CH;X is S, SO, SO.sub.2, CH.sub.2, CHOH or CO;n is 0 or 1;Y is CHR.sup.1 or NR.sup.2, with the proviso that when n is 1 and Y is NR.sup.2, X is SO.sub.2 or CO;Z is CHR.sup.3, CH.sub.2 CH.sub.2, CH.dbd.CH, ##STR2## OCH.sub.2, SCH.sub.2, SOCH.sub.2 or SO.sub.2 CH.sub.2 ; R, R.sup.1, R.sup.2 and R.sup.3 are each independently hydrogen or methyl; andX.sup.1 and X.sup.2 are each independently hydrogen, methyl, trifluoromethyl, phenyl, benzyl, hydroxy, methoxy, phenoxy, benzyloxy, bromo, chloro or fluoro; a pharmaceutically-acceptable cationic salt thereof; or a pharmaceutically-acceptable acid addition salt thereof when A or B is N.

    摘要翻译: 式(I)的低血糖噻唑烷-2,4-二酮衍生物,其中虚线表示键或无键; A和dB各自独立地为CH或N,条件是当A或B为N时,另一个为CH; X是S,SO,SO 2,CH 2,CHOH或CO; n为0或1; Y是CHR1或NR2,条件是当n是1且Y是NR2时,X是SO2或CO; Z是CHR 3,CH 2 CH 2,CH = CH,CH 3,OCH 2,SCH 2,SOCH 2或SO 2 CH 2; R,R1,R2和R3各自独立地为氢或甲基; 苯基,苄基,羟基,甲氧基,苯氧基,苄氧基,溴,氯或氟; X 1和X 2各自独立地为氢,甲基, 其药学上可接受的阳离子盐; 或当A或B为N时,其药学上可接受的酸加成盐。